The International Journal of Tuberculosis and Lung Disease

Tuberculosis elimination and the challenge of the long-term completer [Editorial]
pp. 269-269(1)
Author: Chaulk, C. Patrick

Global tuberculosis control: an optimist's perspective [Editorial]
pp. 270-272(3)
Author: Hopewell, Philip C.

Completion of tuberculosis therapy for patients reported in the United States in 1993
pp. 273-280(8)
Authors: Bloch, A. B.; Cauthen, G. M.; Simone, P. M.; Kelly, G. D.; Dansbury, K. G.; Castro, K. G.

Screening for infection and disease as a tuberculosis control measure among indigents in New York City, 1994–1997
pp. 281-286(6)
Authors: Schluger, N. W.; Huberman, R.; Holzman, R.; Rom, W. N.; Cohen, D. I.

Longitudinal incidence of tuberculosis in South-East Asian refugees after re-settlement
pp. 287-293(7)
Authors: MacIntyre, C. R.; Plant, A. J.

Trend in the annual risk of tuberculous infection in Egypt, 1950 –1996
pp. 294-299(6)
Authors: El Ibiary, S.; de Coster, E. J. M.; Tolba, F. M.; van Maaren, P.; Wasily, L.; van Cleeff, M.; el Saied, K.; Veen, J.; Zaher, H. A. A.; Borgdorff, M. W.

Attitudes and knowledge of newly diagnosed tuberculosis patients regarding the disease, and factors affecting treatment compliance
pp. 300-309(10)
Authors: Liam, C. K.; Lim, K. H.; Wong, C. M. M.; Tang, B. G.

Progress in global tuberculosis control 1995–1996, with emphasis on 22 high-incidence countries
pp. 310-320(11)
Authors: Netto, E. M.; Dye, C.; Raviglione, M. C.; Global Monitoring and Surveillance Project

Self-assessment of tuberculin skin test reactions by drug users with or at risk for human immunodeficiency virus infection
pp. 321-325(5)
Authors: Gourevitch, M. N.; Teeter, R.; Schoenbaum, E. E.; Klein, R. S.

Tuberculin test variability: using the Norwegian Adrenaline-Pirquet method
pp. 326-329(4)
Authors: Jentoft, H. F.; Omenaas, E.; Eide, G. E.; Gulsvik, A.

Risk factors for negative sputum acid-fast bacilli smears in pulmonary tuberculosis: results from Dakar, Senegal, a city with low HIV seroprevalence
pp. 330-336(7)
Authors: Samb, B.; Sow, P. S.; Kony, S.; Maynart-Badiane, M.; Diouf, G.; Cissokho, S.; Bâ, D.; Sané, M.; Klotz, F.; Faye-Niang, M. A.; Mboup, S.; Ndoye, I.; Delaporte, E.; Hane, A. A.; Samb, A.; Coulaud, J.-P.; Coll-Seck, A. M.; Larouzé, B.; Murray, J. F.

Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens
pp. 337-343(7)
Authors: Telzak, E. E.; Chirgwin, K. D.; Nelson, E. T.; Matts, J. P.; Sepkowitz, K. A.; Benson, C. A.; Perlman, D. C.; El-Sadr, W. M.; Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA); AIDS Clinical Trials Group (ACTG), National Institutes for Health

Evaluation of Mycobacteria Growth Indicator Tube (MGIT) for drug susceptibility testing of Mycobacterium tuberculosis
pp. 344-348(5)
Authors: Palomino, J. C.; Traore, H.; Fissette, K.; Portaels, F.

In vitro susceptibility of Mycobacterium kansasii to the difluorinated quinolone sparfloxacin using a broth microdilution and macrodilution MIC system
pp. 349-353(5)
Authors: Royo, P.; Martín-Casabona, N.; Martínez, E.; Andonegui, M.

Application of a computer-directed automated microscope in mycobacteriology [Technical Note]
pp. 354-357(4)
Authors: Somoskövi, A.; Györi, Zs.; Czoboly, N.; Magyar, P.

Jabberwocky [The Lighter Side]
pp. 358-359(2)
Author: Hayden, Christopher

Correspondence
pp. 360-362(3)